Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer.

The effect of anastrozole ('Arimidex', ZD1033), a new, selective, non-steroidal aromatase inhibitor on in vivo aromatisation and plasma oestrogen levels was evaluated in post-menopausal women with breast cancer. Twelve patients progressing after treatment with tamoxifen were randomised to...

Descripción completa

Detalles Bibliográficos
Autores principales: Geisler, J., King, N., Dowsett, M., Ottestad, L., Lundgren, S., Walton, P., Kormeset, P. O., Lønning, P. E.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075919/
https://www.ncbi.nlm.nih.gov/pubmed/8883419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075919/
https://www.ncbi.nlm.nih.gov/pubmed/8883419

Ejemplares similares